Bringing Insights to Life

Interpace Biosciences® (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer.

Learn More

IMPORTANT UPDATE

Specimens and orders for PancraGEN® and fluid chemistry testing
will continue to be accepted until further notice.

ThyGeNEXT®+ThyraMIR®v2 testing for indeterminate thyroid nodules continues to remain available without interruption.

View Details

Latest News

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan

Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
View all news

Sign up for Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

Stock Information

Day Range
52 Week Range
View Investor Relations